China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents

Date : 03/24/2008 @ 9:00AM
Source : PR Newswire
Stock : China Medical Technologies - Ads (MM) (CMED)
Quote : 30.63  0.2 (0.66%) @ 8:00PM
<< BackQuote Chart Financials

 



China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents

BEIJING, March 24 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (NASDAQ:CMED), a leading China-based medical device company that develops, manufactures and markets advanced in- vitro diagnostic ("IVD") products and high intensity focused ultrasound tumor therapy systems, today announces that the Company receives the Conformite Europeenne Mark ("CE Mark") for its two semi-automatic ECLIA analyzers and 15 reagents.

Under the In-Vitro Diagnostic Directive ("IVDD") of the European Union ("EU"), products must meet regulatory requirements in order to qualify for sales and distributions in the EU. A CE Mark indicates that a product complies with the EU regulatory requirements. The Company receives the CE Mark for its two semi-automatic ECLIA analyzers and 15 reagents, including thyroid disorders, diabetes and tumor marker reagents.

"The CE Mark demonstrates that our products meet the IVDD requirements," said Mr. Xiaodong Wu, Chairman and CEO of the Company. "It not only allows us access to new markets but also strengthens our leading position in the advanced IVD market in China."

ECLIA system is a closed IVD system including an analyzer and reagents that are used to detect and quantify particular antibodies or antigens for the diagnosis and analysis of various diseases and disorders. The Company will continue to work on receiving CE Mark for its other ECLIA reagents.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com/ .

For more information, please contact:

China Medical Technologies, Inc.

Winnie Fan Email:

DATASOURCE: China Medical Technologies, Inc.

CONTACT: Winnie Fan of China Medical Technologies, Inc., +86-10-6530-8833,

or

Web Site: http://www.chinameditech.com/

<< Back


China Medical Technologies - Ads (MM) Historical Chart China Medical Technologies - Ads (MM) Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
34 site:2us 081012 00:27 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )